Clarius Group, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$456
+11300.0%
21,3930.0%0.00%
Q4 2022$4
-100.0%
21,393
-5.6%
0.00%
-100.0%
Q3 2022$10,000
-47.4%
22,6740.0%0.00%
-50.0%
Q2 2022$19,00022,6740.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Artal Group S.A. 2,042,666$440.00%
Tower Research Capital LLC (TRC) 25$00.00%
Baader Bank Aktiengesellschaft 73,420$1,2200.00%
Clarius Group, LLC 21,393$4560.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$13,6320.00%
ACADIAN ASSET MANAGEMENT LLC 179,676$20.00%
SIMPLEX TRADING, LLC 3,856$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders